Comparison between Medistep Healthcare IPO and Sundrex Oil IPO.
Medistep Healthcare IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Sundrex Oil IPO is a SME Bookbuilding proposed to list at NSE SME.
| Medistep Healthcare IPO | Sundrex Oil IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Novus Capital Advisors Private Limited | Affinity Global Capital Market Pvt.Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Nirman Share Brokers Pvt.Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Medistep Healthcare IPO is up to ₹15.29 Cr whereas the issue size of the Sundrex Oil IPO is up to ₹30.62 Cr. The final issue price of Medistep Healthcare IPO is ₹43.00 per share and of Sundrex Oil IPO is ₹86.00 per share.
| Medistep Healthcare IPO | Sundrex Oil IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹81.00 per share | |
| Issue Price (Upper) | ₹86.00 per share | |
| Issue Price (Final) | ₹43.00 per share | ₹86.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 35,55,000 shares | 35,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹15.29 Cr | up to ₹30.62 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,55,000 shares | 35,60,000 shares |
| Issue Size Total (Amount) | up to ₹15.29 Cr | up to ₹30.62 Cr |
Medistep Healthcare IPO opens on Aug 08, 2025, while Sundrex Oil IPO opens on Dec 22, 2025. The closing date of Medistep Healthcare IPO and Sundrex Oil IPO is Aug 12, 2025, and Dec 24, 2025, respectively.
| Medistep Healthcare IPO | Sundrex Oil IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 08, 2025 | Dec 22, 2025 |
| Issue Close | Aug 12, 2025 | Dec 24, 2025 |
| Basis Of Allotment (Tentative) | Aug 13, 2025 | Dec 26, 2025 |
| Initiation of Refunds (Tentative) | Aug 14, 2025 | Dec 29, 2025 |
| Credit of Share (Tentative) | Aug 14, 2025 | Dec 29, 2025 |
| Listing date (Tentative) | Aug 18, 2025 | Dec 30, 2025 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Medistep Healthcare IPO P/E ratio is 10.86, as compared to Sundrex Oil IPO P/E ratio of 10.69.
| Medistep Healthcare IPO | Sundrex Oil IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)Medistep Healthcare Ltd.'s revenue increased by 27% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Sundrex Oil Co.Ltd.'s revenue increased by 41% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 93.62 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.96 | 72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.86 | 10.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹61.10 Cr. | ₹115.20 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 29.06 | 35.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 38.91 | 27.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.96 | ₹8.04 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 29.06 | 35.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medistep Healthcare IPO Retail Individual Investors (RII) are offered 17,79,000 shares while in Sundrex Oil IPO retail investors are offered 17,79,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Medistep Healthcare IPO and 75,200 shares in Sundrex Oil IPO.
| Medistep Healthcare IPO | Sundrex Oil IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 1,89,000 shares | 1,88,800 shares |
| QIB | 0 shares | 75,200 shares |
| NII | 17,76,000 shares | 13,96,800 shares |
| RII | 17,79,000 shares | 20,89,600 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,55,000 shares | 35,61,600 shares |
Medistep Healthcare IPO subscribed 382.14x in total, whereas Sundrex Oil IPO subscribed 1.53x.
| Medistep Healthcare IPO | Sundrex Oil IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 289.15x | 1.01x |
| Big NII (times) | 0.97x | |
| Small NII (times) | 1.10x | |
| RII (times) | 461.11x | 1.90x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 382.14x | 1.53x |
